Deprecated: Required parameter $cat_id follows optional parameter $type in /www/wwwroot/ebimall.com/systems/hong.php on line 2088

Deprecated: Required parameter $where follows optional parameter $tree_id in /www/wwwroot/ebimall.com/systems/hlb.php on line 3505
Solulink/CleanCap<sup>®</sup> Cre mRNA (5moU) - (L-7211)/1/L-7211-100188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

Solulink/CleanCap® Cre mRNA (5moU) - (L-7211)/1/L-7211-100

Description
Product Details
Technical Documents
FAQs
Certificate of Analysis
Intellectual Property
References

Description

NLS-Cre Recombinase mRNA is a capped and polyadenylated messenger RNA encoding Cre recombinase fused to a nuclear localization sequence (NLS). Cre recombinase is a tyrosine recombinase that catalyzes recombination between two loxP sites.This mRNA is capped using CleanCap, TriLink"s proprietary co-transciptional capping method, which results in the naturally occuring Cap 1 structure with high capping efficiency. It is polyadenylated, modified with 5-methoxyuridine and optimized for mammalian systems. It mimics a fully processed mature mRNA.

Product Details

Catalog NoL-7211
PurityPasses Agarose Gel Mobility
Length1350 nucleotides
Base CompositionFully substituted with 5-Methoxy-U
Concentration1.0 mg/mL
Buffer1 mM Sodium Citrate pH 6.4
Conversion Factor40 µg/OD260
Recommended StorageAt or below -40°C
ApplicationCRISPR, Immunotherapeutics, Recombinases
Other Name(s)CleanCap® NLS-Cre Recombinase mRNA (5-methoxyuridine)

Technical Documents

L-7211 Safety Data Sheet

L-7211 Product Insert

CleanCap Cre ORF Sequence


FAQs

Ask an Expert

Certificate of Analysis

CoA Search Tool

Intellectual Property

CleanCap For Research Use Only. Not for use in humans. Not for use in diagnostic or therapeutic purposes. For additional licensing restrictions, please see the license agreement at trilinkbiotech.com/cleancap-research-license. Patent or patent pending,see trilinkbiotech.com/legal-notices.

Products are for research use only, not for use in diagnostic or therapeutic procedures or for use in humans. Products are not for resale without express written permission of Seller. No license under any patent or other intellectual property right of Seller or its licensors is granted or implied by the purchase unless otherwise provided in writing.

TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser"s sole responsibility.


References

Webber, Beau R.; Osborn, Mark J.; McElroy, Amber N.; Twaroski, Kirk; Lonetree, Cara-Lin; DeFeo, Anthony P.; Xia, Lily; Eide, Cindy; Lees, Christopher J.; McElmurry, Ron T.; Riddle, Megan J.; Kim, Chong Jai; Patel, Dharmeshkumar D.; Blazar, Bruce R.; Tolar, Jakub . CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa.

Kauffman, Kevin J.; Oberli, Matthias A.; Dorkin, J. Robert; Hurtado, Juan E.; Kaczmarek, James C.; Bhadani, Shivani; Wyckoff, Jeff; Langer, Robert; Jaklenec, Ana; Anderson, Daniel G. . Rapid, Single-Cell Analysis and Discovery of Vectored mRNA Transfection In Vivo witha loxP-Flanked tdTomato Reporter Mouse.


新闻动态
行业前沿
技术文章
最新产品